Julie Grill brings expertise in the design and conduct of clinical trials for medical devices and in navigating the associated worldwide regulatory environment.
Prior to joining SPR’s parent company NDI Medical, she was Director of Clinical Studies and Regulatory Affairs for NeuroControl Corporation, leading multi-center studies, and preparing and obtaining approval for IDE, PMA, HDE, 510k, and CE mark applications for various neurostimulation products.
She has also worked as a reviewer in the Neurological Devices Branch of the U.S. Food and Drug Administration. She has a master's degree in biomedical engineering from Case Western Reserve University and a B.S. in biomedical engineering from Duke University.